Insmed (INSM) FCF Margin (2011 - 2026)
Insmed (INSM) recorded quarterly FCF Margin of 73.94% in Q1 2026, up 26.16% quarter-over-quarter from 100.13% in Q4 2025, and up 21926.0% on a YoY basis from N/an in Q1 2025.
Insmed (INSM) FCF Margin (2011 - 2026) Analysis & Trends
Insmed's FCF Margin history runs 11 years deep, the most recent figure standing at 73.94% for Q1 2026.
- In Q1 2026, FCF Margin rose 21926.0% year-over-year to 73.94%; the TTM figure through Mar 2026 stood at 112.45% (up 9468.0% YoY), while the FY2025 annual figure was 159.55%, up 3450.0% from the prior year.
- FCF Margin was 73.94% for Q1 2026 at Insmed, up from 100.13% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 73.94% in Q1 2026 to a low of 293.2% in Q1 2025.
- Historically, FCF Margin has averaged 177.11% across 5 years, with a median of 176.03% in 2023.
- The sharpest annual moves came in 2025 and 2026: FCF Margin tumbled 5101 bps in 2025, then soared 21926 bps in 2026.
- A 5-year view of FCF Margin shows it stood at 181.85% in 2022, then climbed by 13 bps to 158.88% in 2023, then dropped by 22 bps to 194.13% in 2024, then soared by 48 bps to 100.13% in 2025, then rose by 26 bps to 73.94% in 2026.
- The last three FCF Margin figures came in at 73.94% (Q1 2026), 100.13% (Q4 2025), and 156.09% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -3.98% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Insmed | 19.79 Bn | 18.57 Bn | 258.54 Mn | -73.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -73.94% |
| Dec 31, 2025 | -100.13% |
| Sep 30, 2025 | -156.09% |
| Jun 30, 2025 | -194.62% |
| Mar 31, 2025 | -293.20% |
| Dec 31, 2024 | -194.13% |
| Sep 30, 2024 | -197.60% |
| Jun 30, 2024 | -143.61% |
| Mar 31, 2024 | -249.95% |
| Dec 31, 2023 | -158.88% |
| Sep 30, 2023 | -176.03% |
| Jun 30, 2023 | -165.32% |
| Mar 31, 2023 | -229.55% |
| Dec 31, 2022 | -181.85% |
| Sep 30, 2022 | -133.49% |
| Jun 30, 2022 | -161.31% |
| Mar 31, 2022 | -201.22% |
| Dec 31, 2021 | -151.94% |
| Sep 30, 2021 | -164.52% |
| Jun 30, 2021 | -173.98% |